Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications (SISCO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04322188
Recruitment Status : Completed
First Posted : March 26, 2020
Last Update Posted : June 1, 2020
Sponsor:
Information provided by (Responsible Party):
Giuseppe Gritti, A.O. Ospedale Papa Giovanni XXIII